ACADIA PHARMACEUTICALS INC. Form 4 Filing

This filing details stock transactions by James M. Daly, a director at ACADIA PHARMACEUTICALS INC. On May 29, 2026, Mr. Daly acquired 8,107 shares of Common Stock. Additionally, he was granted 16,004 Director Stock Options and 9,311 Restricted Stock Units, both convertible to Common Stock. The Restricted Stock Units were partially disposed of (8,107 units) and partially acquired (9,311 units), with vesting conditions mentioned in footnotes. The options have an exercise price of $21.66 and vest quarterly over one year. All transactions were reported on Form 4.